Although SRC prognosis has improved markedly, SRC remains a severe manifestation of SSc, despite treatment with angiotensin-converting enzyme inhibitor and dialysis. CSs contributed significantly to SRC occurrence.
Rheumatology (Oxford, England)
Department of Internal Medicine, Hôpital Cochin, Paris Cedex 14, France. loic.guillevin [at] cch.aphp.fr
Rheumatology (Oxford). 2012 Mar;51(3):460-7
© Galenicom 1999-2013